UNICA IRIS Institutional Research Information System

TRONCI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 84.141
NA - Nord America 3.645
AS - Asia 1.339
SA - Sud America 196
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 89.364
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 83.236
US - Stati Uniti d'America 3.601
SG - Singapore 528
CN - Cina 461
UA - Ucraina 245
DE - Germania 204
SE - Svezia 169
BR - Brasile 157
VN - Vietnam 113
FI - Finlandia 82
GB - Regno Unito 70
FR - Francia 61
HK - Hong Kong 50
KR - Corea 41
IN - India 37
CA - Canada 30
RU - Federazione Russa 22
IQ - Iraq 20
AR - Argentina 18
BD - Bangladesh 15
JP - Giappone 13
BE - Belgio 11
MX - Messico 10
NL - Olanda 10
PK - Pakistan 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 8
ID - Indonesia 8
KE - Kenya 8
CL - Cile 7
ES - Italia 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
SA - Arabia Saudita 6
EG - Egitto 5
EC - Ecuador 4
MA - Marocco 4
PL - Polonia 4
TH - Thailandia 4
EU - Europa 3
MY - Malesia 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
AU - Australia 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
IE - Irlanda 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 89.364
Salva come PNG Salva come JPEG
Città #
Cagliari 79.704
Uta 3.352
Fairfield 420
Woodbridge 360
Ashburn 330
Singapore 257
Chandler 203
Ann Arbor 201
Houston 183
Wilmington 179
San Jose 172
Seattle 152
Cambridge 151
Jacksonville 126
Nyköping 121
Boardman 114
Beijing 113
Dallas 110
Dearborn 108
Los Angeles 53
Nanjing 53
Shanghai 53
Santa Clara 48
Hong Kong 43
Ho Chi Minh City 42
The Dalles 41
Helsinki 39
Seoul 38
Lauterbourg 36
New York 36
Council Bluffs 24
Boston 23
Milan 23
Hefei 22
San Diego 22
Hanoi 20
Guangzhou 14
Munich 14
Buffalo 13
Dong Ket 12
Tianjin 12
Tokyo 12
Brussels 11
Changsha 11
Nanchang 11
Redwood City 11
Shenyang 11
São Paulo 11
Verona 11
Frankfurt am Main 10
Mountain View 10
Toronto 10
Hebei 9
Sassari 9
London 8
Montreal 8
Norwalk 8
Orem 8
Phoenix 8
Redondo Beach 8
Baghdad 7
Chennai 7
Falls Church 7
Hangzhou 7
Nairobi 7
New Delhi 7
Turku 7
Brno 6
Brooklyn 6
Da Nang 6
Jinan 6
Johannesburg 6
Oristano 6
Padova 6
Rome 6
Washington 6
Central 5
San Francisco 5
Stockholm 5
Ankara 4
Atlanta 4
Florence 4
Grottammare 4
Jiaxing 4
Lahore 4
Ningbo 4
Orange 4
Pune 4
Zhengzhou 4
Amsterdam 3
Belo Horizonte 3
Betim 3
Biên Hòa 3
Borås 3
Brasília 3
Camaçari 3
Casablanca 3
Chicago 3
Clifton 3
Columbus 3
Totale 87.413
Salva come PNG Salva come JPEG
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.815
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. 4.330
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.290
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.075
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia 3.687
Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats 3.576
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.544
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation 3.457
null 2.940
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 2.869
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia 2.580
The serotonergic system in levodopa-induced dyskinesia 2.559
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.360
null 2.298
null 2.247
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation 2.236
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia 2.190
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations 2.167
Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease 2.166
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study 2.155
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.108
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.791
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and5-HT1B receptor agonists in the rat Parkinson model 1.546
null 1.471
BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia 1.409
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 1.316
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.283
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.248
null 1.194
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats 1.176
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease 1.121
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease 1.087
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 1.085
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 1.076
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.052
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.043
null 1.012
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dyskinesia 977
null 967
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dynskinesia 955
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 926
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment 876
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats 693
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 315
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 276
Totale 89.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.547 0 0 0 0 0 0 0 0 0 0 961 586
2021/20223.592 394 366 173 182 253 273 204 158 271 431 492 395
2022/20235.204 349 569 563 435 460 580 293 349 389 406 545 266
2023/20245.597 227 174 225 283 508 834 880 378 214 395 604 875
2024/202516.813 4.751 4.481 4.113 1.153 579 619 676 52 124 73 89 103
2025/20262.367 186 93 249 214 182 170 695 131 173 268 6 0
Totale 89.544